People who recover from COVID-19 have antibodies against the virus in the plasma component of their blood. That COVID-19 convalescent plasma, or CCP, is now being used to treat other patients who have the disease.
As of April 27, 13 patients in our UCHealth Northern Colorado Region hospitals have been treated with CCP.
“Conceptually, it makes a lot of sense, but we are somewhat in the research realm,” says Dr. Steven Schuster, a hematologist and medical director of oncology research for UCHealth in northern Colorado, who is helping coordinate the process.
Read more about the treatment, and meet a nurse who recovered from COVID-19 and donated her CCP at UCHealth Garth Englund Blood Center.